BRC News

The steroid dexamethasone may substantially reduce mortality in severely ill Covid-19 patients, according to initial results from a national priority trial in which UCLH is involved.

In this Q&A ENT surgeon at UCLH Prof Martin Birchall tells us about the technology his team are testing to improve communication while wearing personal protective equipment (PPE).

A new study at UCLH will look into the impact of COVID-19 infection on patients undergoing chemotherapy for treatment of Acute Myeloid Leukaemia (AML), a type of cancer that affects the blood cells. This study will involve 34 NHS hospitals and the lead for UCLH will be Dr Jenny O’Nions.

The BRC has today launched an animated film explaining Huntington’s disease and efforts to correct the impact of the faulty gene that causes it.

UCL and UCLH are leading two studies looking at the link between Covid-19 and heart disease.

A new consortium consisting of UCL, the UCLH BRC and the Medical Research Council (MRC) Harwell Institute in Oxfordshire is to investigate and develop novel treatments for otitis media (OM) – the middle ear disease.

Patients on immunosuppressive medications for rheumatic and musculoskeletal diseases such as arthritis and lupus can be reassured that these drugs do not increase the risks posed by COVID-19.

The charity In2ScienceUK and the BRC are looking for researchers to offer support and advice this summer to disadvantaged young people who are interested in STEM degrees and careers.

UCLH is contributing to a national priority trial of the drug ruxolitinib in patients with Covid-19 pneumonia (infection of the lungs).

Over 50 research studies in diseases other than Covid-19 have been the green light to restart at UCLH.

People with MS and researchers at Queens Square have worked together to produce a film telling the human story of clinical research.

A large international trial involving UCL and UCLH has found that pembrolizumab, a form of immunotherapy, more than doubled the progression free survival time of patients with a specific subtype of advanced bowel cancer, when compared with chemotherapy.

UCL has announced a new collaboration with Cerveau Technologies, which will enable UCL to manufacture and distribute the imaging agent called [18F]MK-6240.

UCLH is to trial the COVID-19 vaccine developed by the University of Oxford in healthy staff volunteers.

UCLH Research Directorate has begun the process of reopening studies paused during the Covid-19 pandemic.